Lung Ultrasonography in the Evaluation of Late Sequelae of COVID-19 Pneumonia-A Comparison with Chest Computed Tomography: A Prospective Study.

Autor: Zimna K; I Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland., Sobiecka M; I Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland., Wakuliński J; Department of Radiology, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland., Wyrostkiewicz D; I Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland., Jankowska E; I Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland., Szturmowicz M; I Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland., Tomkowski WZ; I Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.

Publikováno v: Viruses [Viruses] 2024 Jun 03; Vol. 16 (6). Date of Electronic Publication: 2024 Jun 03.

The Presence of T Allele (rs35705950) of the MUC5B Gene Predicts Lower Baseline Forced Vital Capacity and Its Subsequent Decline in Patients with Hypersensitivity Pneumonitis.

Autor: Lewandowska KB; 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Szturmowicz M; 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Lechowicz U; Department of Genetics and Clinical Immunology, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Franczuk M; Department of Respiratory Physiopathology, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Błasińska K; Department of Radiology, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Falis M; 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Błaszczyk K; 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Sobiecka M; 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Wyrostkiewicz D; 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Siemion-Szcześniak I; 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Bartosiewicz M; 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Radwan-Röhrenschef P; 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Roży A; Department of Genetics and Clinical Immunology, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Chorostowska-Wynimko J; Department of Genetics and Clinical Immunology, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland., Tomkowski WZ; 1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 28; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 28.

Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis.

Autor: Sobiecka M; 1st Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland., Szturmowicz M; 1st Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland., Lewandowska KB; 1st Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland., Barańska I; Department of Radiology, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland., Zimna K; 1st Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland., Łyżwa E; 1st Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland., Dybowska M; 1st Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland., Langfort R; Department of Pathology, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland., Radwan-Röhrenschef P; 1st Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland., Roży A; Department of Genetics and Clinical Immunology, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland., Tomkowski WZ; 1st Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland.

Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Mar 01; Vol. 13 (5). Date of Electronic Publication: 2023 Mar 01.

Pulmonary amyloidosis mimicking interstitial lung disease and malignancy - A case series with a review of a pulmonary patterns.

Autor: Zimna K; Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland., Sobiecka M; Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland., Langfort R; Department of Pathology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland., Błasińska K; Department of Radiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland., Tomkowski WZ; Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.

Publikováno v: Respiratory medicine case reports [Respir Med Case Rep] 2021 May 11; Vol. 33, pp. 101427. Date of Electronic Publication: 2021 May 11 (Print Publication: 2021).

Thromboprophylaxis by rivaroxaban, aspirin, both, or placebo after hospitalization for medical illness.

Autor: Tomkowski WZ; Cardio-Pulmonary Intensive Care, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland. Electronic address: w.tomkowski@igichp.edu.pl., Davidson BL; Providence Health System, Seattle, WA, United States of America. Electronic address: brucedavidson@pobox.com.

Publikováno v: Thrombosis research [Thromb Res] 2019 Aug; Vol. 180, pp. 62-63. Date of Electronic Publication: 2019 Jun 11.